Saliva and serum levels of B-cell activating factors and tumor necrosis factor-a in patients with periodontitis

Journal of Periodontology

Volumn 85, Issue 2, 2014, Pages 270-280

  Gümüş, Pýnar ^a   Nizam, Nejat ^a   Lappin, David F ^b   Buduneli, Nurcan ^a  

^a EGE UNIVERSITY   (Turkey)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

A proliferation inducing ligand protein; B cell activating factor; Periodontitis; Saliva; Serum; Tumor necrosis factoralpha

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 10; INTERLEUKIN 6; TNFSF13 PROTEIN, HUMAN; TNFSF13B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGGRESSIVE PERIODONTITIS; ALVEOLAR BONE LOSS; BLOOD; CHRONIC PERIODONTITIS; CLASSIFICATION; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PERIODONTIUM; SALIVA; SMOKING; TOOTH PLAQUE;

ADULT; AGGRESSIVE PERIODONTITIS; ALVEOLAR BONE LOSS; B-CELL ACTIVATING FACTOR; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTIUM; SALIVA; SMOKING; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885967227     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2013.130117     Document Type: Article

References (55)

1. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
2. Sun Y, Guo QM, Liu DL, Zhang MZ, Shu R. In vivo expression of Toll-like receptor 2, Toll-like receptor 4, CSF2 and LY64 in Chinese chronic periodontitis patients. Oral Dis 2010;16:343-350.
3. Mackler BF, Frostad KB, Robertson PB, Levy BM. Immunoglobulin bearing lymphocytes and plasma cells in human periodontal disease. J Periodontal Res 1977;12:37-45.
4. Seymour GJ, Greenspan JS. The phenotypic characterization of lymphocyte subpopulations in established human periodontal disease. J Periodontal Res 1979;14:39-46.
5. Seymour GJ, Powell RN, Davies WI. Conversion of a stable T-cell lesion to a progressive B-cell lesion in the pathogenesis of chronic inflammatory peri-odontal disease: An hypothesis. J Clin Periodontol 1979;6:267-277.
6. Lappin DF, Koulouri O, Radvar M, Hodge P, Kinane DF. Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohisto-chemistry. J Clin Periodontol 1999;26:183-189.
7. Hadj-Kacem H, Rebuffat S, Mnif-Féki M, Belguith-Maalej S, Ayadi H, Péraldi-Roux S. Autoimmune thyroid diseases: Genetic susceptibility of thyroid-specific genes and thyroid autoantigens contributions. Int J Immunogenet 2009;36:85-96.
8. Mackay F, Silveira PA, Brink R. B cells and the BAFF/APRIL axis: Fast-forward on autoimmunity and signaling. Curr Opin Immunol 2007;19:327-336.
9. Townsend MJ, Monroe JG, Chan AC. B-cell targeted therapies in human autoimmune diseases: An updated perspective. Immunol Rev 2010;237:264-283.
10. Ng LG, Mackay CR, Mackay F. The BAFF/APRIL system: Life beyond B lymphocytes. Mol Immunol 2005;42:763-772.
11. Moisini I, Davidson A. BAFF: A local and systemic target in autoimmune diseases. Clin Exp Immunol 2009;158:155-163.
12. Liu K, Zhang Y, Hu S, et al. Increased levels of BAFF and APRIL related to human active pulmonary tuberculosis. PLoS ONE 2012;7:e38429.
13. Haber J, Wattles J, Crowley M, Mandell R, Joshipura K, Kent RL. Evidence for cigarette smoking as a major risk factor for periodontitis. J Periodontol 1993;64: 16-23.
14. Ketabi M, Hirsch RS. The effects of local anesthetic containing adrenaline on gingival blood flow in smokers and non-smokers. J Clin Periodontol 1997;24:888-892.
15. Calsina G, Ramon JM, Echeverria JJ. Effects of smoking on periodontal tissues. J Clin Periodontol 2002;29:771-776.
16. Seow WK, Thong YH, Nelson RD, MacFarlane GD, Herzberg MC. Nicotine-induced release of elastase and eicosanoids by human neutrophils. Inflammation 1994;18:119-127.
17. Barbour SE, Nakashima K, Zhang JB, et al. Tobacco and smoking: Environmental factors that modify the host response (immune system) and have an impact on periodontal health. Crit Rev Oral Biol Med 1997;8:437-460.
18. van Eeden SF, Hogg JC. The response of human bone marrow to chronic cigarette smoking. Eur Respir J 2000;15:915-921.
19. Palmer RM, Wilson RF, Hasan AS, Scott DA. Mechanisms of action of environmental factors-Tobacco smoking. J Clin Periodontol 2005;32(Suppl. 6): 180-195.
20. Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF. Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci (Lond) 1995;88: 485-489.
21. Boström L, Linder LE, Bergström J. Smoking and cervicular fluid levels of IL-6 and TNF-alpha in periodontal disease. J Clin Periodontol 1999;26: 352-357.
22. Buduneli N, Buduneli E, Kardesler L, Lappin D, Kinane DF. Plasminogen activator system in smokers and non-smokers with and without periodontal disease. J Clin Periodontol 2005;32:417-424.
23. Buduneli N, Kardesxler L, Isxik H, et al. Effects of smoking and gingival inflammation on salivary antioxidant capacity. J Clin Periodontol 2006;33: 159-164.
24. Erley KJ, Swiec GD, Herold R, Bisch FC, Peacock ME. Gingival recession treatment with connective tissue grafts in smokers and non-smokers. J Peri-odontol 2006;77:1148-1155.
25. Quigley GA, Hein JW. Comparative cleansing efficiency of manual and power brushing. J Am Dent Assoc 1962;65:26-29.
26. Le Pottier L, Bendaoud B, Renaudineau Y, Youinou P, Pers JO, Daridon C. New ELISA for B cell-activating factor. Clin Chem 2009;55:1843-1851.
27. Mackay F, Schneider P, Rennert P, Browning J. BAFF and APRIL: A tutorial on B cell survival. Annu Rev Immunol 2003;21:231-264.
28. Scapini P, Hu Y, Chu CL, et al. Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice. J Exp Med 2010;207:1757-1773.
29. Assi LK, Wong SH, Ludwig A, et al. Tumor necrosis factor-alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid joint arthritis. Arthritis Rheum 2007;56:1776-1786.
30. Bergström J. Tobacco smoking and chronic destructive periodontal disease. Odontology 2004;92:1-8.
31. Graves DT, Cochran D. The contribution of inter-leukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003;74:391-401.
32. Garlet GP. Destructive and protective roles of cytokines in periodontitis: A re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 2010;89:1349-1363.
33. Preshaw PM, Taylor JJ. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of peri-odontitis? J Clin Periodontol 2011;38(Suppl. 11): 60-84.
34. Goutoudi P, Diza E, Arvanitidou M. Effect of peri-odontal therapy on crevicular fluid interleukin-1beta and interleukin-10 levels in chronic periodontitis. J Dent 2004;32:511-520.
35. Bartold PM, Marshall RI, Haynes DR. Periodontitis and rheumatoid arthritis: A review. J Periodontol 2005;76(Suppl. 11):2066-2074.
36. Pers J-O, d'Arbonneau F, Devauchelle-Pensec V, Saraux A, Pennec Y-L, Youinou P. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome? Arthritis Rheum 2005;52:2411-2414.
37. Nilsson M, Kopp S. Gingivitis and periodontitis are related to repeated high levels of circulating tumor necrosis factor-alpha in patients with rheumatoid arthritis. J Periodontol 2008;79:1689-1696.
38. Hemingway F, Taylor R, Knowles HJ, Athanasou NA. RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II. Bone 2011;48:938-944.
39. Kotsovilis S, Tseleni-Balafouta S, Charonis A, Fourmousis I, Nikolidakis D, Vrotsos JA. Syndecan-1 immunohistochemical expression in gingival tissues of chronic periodontitis patients correlated with various putative factors. J Periodontal Res 2010;45: 520-531.
40. Pers JO, Saraux A, Pierre R, Youinou P. Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. J Peri-odontol 2008;79:1645-1651.
41. Yavuzyilmaz E, Yamalik N, Calgüner M, Ersoy F, Baykara M, Yeniay I. Clinical and immunological characteristics of patients with rheumatoid arthritis and periodontal disease. J Nihon Univ Sch Dent 1992;34:89-95.
42. Mercado F, Marshall RI, Klestov AC, Bartold PM. Is there a relationship between rheumatoid arthritis and periodontal disease? J Clin Periodontol 2000; 27:267-272.
43. Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and peri-odontitis. J Periodontol 2001;72:779-787.
44. Seyler TM, Park YW, Takemura S, et al. BLyS and APRIL in rheumatoid arthritis. J Clin Invest 2005; 115:3083-3092.
45. Scapini P, Carletto A, Nardelli B, et al. Proinflam-matory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: Implications for inflammatory diseases. Blood 2005;105:830-837.
46. Koyama T, Tsukamoto H, Miyagi Y, et al. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann Rheum Dis 2005;64:1065-1067.
47. McNearney T, Baethge BA, Cao S, Alam R, Lisse JR, Westlund KN. Excitatory amino acids, TNF-alpha, and chemokine levels in synovial fluids of patients with active arthropathies. Clin Exp Immunol 2004;137:621-627.
48. Ozcxaka Ö, Nalbantsoy A, Buduneli N. Salivary osteocalcin levels are decreased in smoker chronic periodontitis patients. Oral Dis 2011;17:200-205.
49. Ozcxaka Ö, Bicxakci N, Pussinen P, Sorsa T, Köse T, Buduneli N. Smoking and matrix metalloproteinases, neutrophil elastase and myeloperoxidase in chronic periodontitis. Oral Dis 2011;17:68-76.
50. Ozcxaka Ö, Nalbantsoy A, Köse T, Buduneli N. Plasma osteoprotegerin levels are decreased in smoker chronic periodontitis patients. Aust Dent J 2010;55: 405-410.
51. Buduneli N, Ö zcxaka Ö, Nalbantsoy A. Salivary and plasma levels of Toll-like receptor 2 and Toll-like receptor 4 in chronic periodontitis. J Periodontol 2011;82:878-884.
52. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993;694:72-77.
53. Kaufman E, Lamster IB. Analysis of saliva for peri-odontal diagnosis-A review. J Clin Periodontol 2000; 27:453-465.
54. Edgar WM. Saliva: Its secretion, composition and functions. Br Dent J 1992;172:305-312.
55. Chapple IL, Mason GI, Garner I, et al. Enhanced chemiluminescent assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid. Ann Clin Biochem 1997;34:412-421.